Sucraid

Sucraid Uses, Dosage, Side Effects, Food Interaction and all others data.

Sucraid is a liquid enzyme preparation from S.cerevisiae used for the treatment of congenital sucrose-isomaltase deficiency (CSID). People with CSID have variable amounts of sucrose-isomaltase enzyme activity and therefore have issues metabolizing dietary disaccharide sucrose causing chronic or intermittent watery diarrhea in infants and children. Treatment options for these patients are limited and usually consists of a lifelong sucrose-free diet; therefore, sacrosidase offers a potential alternative for symptom relief.

Sucraid
Uses
Dosage
Side Effect
Precautions
Interactions
Uses during Pregnancy
Uses during Breastfeeding
Accute Overdose
Food Interaction
Half Life
Volume of Distribution
Clearance
Interaction With other Medicine
Contradiction
Storage

Trade Name	Sucraid
Availability	Prescription only
Generic	Sacrosidase
Sacrosidase Other Names	Sacrosidase
Related Drugs	Sucraid
Weight	8500intlunits/ml,
Type	Oral solution
Groups	Approved
Therapeutic Class
Manufacturer
Available Country	United States,
Last Updated:	September 19, 2023 at 7:00 am

Uses

Sucraid is an enzyme replacement therapy used for the treatment of congenital sucrase-isomaltase deficiency (CSID).

For the treatment of congenital sucrose-isomaltase deficiency (CSID).

Sucraid is also used to associated treatment for these conditions: Sucrase-isomaltase deficiency

How Sucraid works

Sucraid is a [beta]-fructofuranoside fructohydrolase that hydrolyzes sucrose. Unlike human intestinal sucrase-isomaltase, it has no activity with oligosaccharides containing 1,6 glucosyl bonds.

Food Interaction

No interactions found.

[Moderate] GENERALLY AVOID: The enzyme activity of sacrosidase is diminished if it is taken with acidic foods.

MANAGEMENT: The manufacturer recommends that the drug not be taken with fruit juice.

Sucraid Disease Interaction

Major: allergiesModerate: diabetes

Elimination Route

It has been suggested that sucrose is better absorbed (and sacrosidase activity preserved) when patients were given milk before sacrosidase rather than consuming the enzyme product alone. Therefore, it has been recommended to take half dose of sacrosidase just after a protein-containing meal, and the other half of the dose approximately half-way through the meal.